Tolemy Bio lands €1.4M to power AI-driven cell biology

Cambridge-based biotechstartup Tolemy Bio has raised €1.4 million in pre-seed funding to advance itsAI-enabled technology for cell biology research and biopharma development. Theround was led by Norrs…

NanoStruct raises €2.6M Seed to bring same-day pathogen detection to the food industry

German-based deeptech startup NanoStruct has raised €2.6 million Seed funding. Founded by Dr Henriette Maaß, Enno Schatz, and Kai Leibfried, the company develops nanostructured sensor chips for the…

EnteroBiotix secures £19M to support IBS microbiome clinical trial

Glasgow-basedlife sciences company EnteroBiotix has secured £19 million in funding tosupport the advancement of its microbiome-based therapies, including a large-scale clinical trial targeting irritab…

Helical secures $10M to advance virtual AI lab for pharma research

Helical, a biotechnologycompany developing a virtual AI lab for pharmaceutical research anddevelopment, has raised $10 million in seed funding. The round was led byredalpine, with participation from G…

Generare secures €20M to scale molecular discovery platform

Generare,a Paris-based biotechnology company focused on generating molecular data fordrug development, has raised €20 million in a Series A funding round. The roundwas co-led by Alven and Daphni, with…

Semarion raises $3.8M to scale cell assay technology

Semarion, a University ofCambridge spin-out from the Cavendish Laboratory, has raised $3.8 million (£2.9million) in funding to support the expansion of its cell-based screeningtechnology. The round wa…

Inside the stealthy startup that pitched brainless human clones
Inside the stealthy startup that pitched brainless human clones

After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing. In an interview with Wired, R3 listed three investors: billionaire Tim Draper, the Singapore-based fund Immortal…

Building the path to 3D-printed organs, Cellbricks raises €10M for biofabricated tissue implants

Berlin-founded biotech startup Cellbricks Therapeutics has raised €10 million to advance its goal of 3D-printed organs, beginning with biofabricated human tissue implants. If successful, Cellbricks i…

NanoZymeX secures €160K to advance lipid nanoparticle enzyme therapies for rare diseases

Biotech startup NanoZymeX has obtained €160,000 (CHF 150,000) from Venture Kick to advance a new platform for enzyme replacement therapy using lipid nanoparticles. Spun out of research at the Univers…

Rivia raises $15M to fix the broken data infrastructure behind clinical trials

Rivia, the Zurich-based data engine for clinical trial intelligence, today announced a $15 million Series A led by Earlybird, with participation from Defiant and existing investors Speedinvest, Amino …